» Articles » PMID: 30157691

Cognitive Function in Patients with Coronary Artery Disease: A Literature Review

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2018 Aug 31
PMID 30157691
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objective Cognitive function impairment is a well-documented complication of cerebrovascular disease (CBVD). Less is known about what factors affect the deterioration of cognitive function in patients with coronary artery disease (CAD). The aim of this review is to explore recent studies investigating factors associated with cognitive function in patients with CAD. Methods Studies published from 2010 to 2016 were identified through a systematic search of MEDLINE/PubMed and were included if they addressed factors affecting cognitive function in the CAD population. Results Of the 227 publications identified, 32 were selected for the review. Five factors tentatively affecting cognitive function in patients with CAD were identified: coronary artery bypass grafting (CABG) surgery, apolipoprotein E4 (APOE4) genotype, left ventricular ejection fraction (LVEF), medication use, and various hormones and biomarkers. Conclusion New techniques in CABG surgery have proven to alleviate postoperative cognitive decline. Researchers are still debating the effects of APOE4 genotype, LVEF, and the use of cardiovascular medications on cognitive function. Thyroid hormones and biomarkers are associated with cognitive function, but the exact nature of the association is debatable. Longitudinal studies should clarify those associations. In addition, cross-sectional studies addressing other causes of cognitive decline in patients with CAD are warranted.

Citing Articles

Cognitive changes in people with diabetes with lower extremity complications compared to people with diabetes without lower extremity complications: a systematic review and meta-analysis.

Karunathilaka N, Parker C, Lazzarini P, Chen P, Katsanos C, MacAndrew M BMC Endocr Disord. 2024; 24(1):258.

PMID: 39609829 PMC: 11605952. DOI: 10.1186/s12902-024-01774-3.


Liver Status Assessment After Coronary Artery Bypass Grafting.

Ludusanu A, Ciuntu B, Tanevski A, Fotache M, Radu V, Burlacu A Cureus. 2024; 16(10):e72210.

PMID: 39583384 PMC: 11583995. DOI: 10.7759/cureus.72210.


A randomised controlled trial assessing the effects of weather sensitivity profile and walking in nature on the psychophysiological response to stress in individuals with coronary artery disease. A study protocol.

Martinaitiene D, Sampaio F, Demetrovics Z, Gjoneska B, Portacenko J, Damuleviciute A BMC Psychol. 2024; 12(1):82.

PMID: 38374158 PMC: 10877807. DOI: 10.1186/s40359-024-01574-3.


Effect of different coronary artery revascularization procedures on cognition: A systematic review.

Althukair W, Nuhmani S Heliyon. 2023; 9(9):e19735.

PMID: 37810024 PMC: 10558982. DOI: 10.1016/j.heliyon.2023.e19735.


Contribution of Obstructive Sleep Apnoea to Cognitive Functioning of Males With Coronary Artery Disease: A Relationship With Endocrine and Inflammatory Biomarkers.

Kazukauskiene N, Fineberg N, Podlipskyte A, Bunevicius A, Linares N, Poitras M Front Neurosci. 2022; 16:899597.

PMID: 35924228 PMC: 9340787. DOI: 10.3389/fnins.2022.899597.


References
1.
Newman M, Kirchner J, Phillips-Bute B, Gaver V, Grocott H, Jones R . Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001; 344(6):395-402. DOI: 10.1056/NEJM200102083440601. View

2.
Krannich J, Tobias T, Broscheit J, Leyh R, Mullges W . Diabetes severely affects attentional performance after coronary artery bypass grafting. J Cardiothorac Surg. 2012; 7:115. PMC: 3504518. DOI: 10.1186/1749-8090-7-115. View

3.
Satizabal C, Beiser A, Seshadri S . Incidence of Dementia over Three Decades in the Framingham Heart Study. N Engl J Med. 2016; 375(1):93-4. PMC: 6374770. DOI: 10.1056/NEJMc1604823. View

4.
Mazereeuw G, Herrmann N, Xu H, Figeys D, Oh P, Bennett S . Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating study. J Neuroinflammation. 2014; 11:119. PMC: 4096420. DOI: 10.1186/1742-2094-11-119. View

5.
Yagi S, Hara T, Ueno R, Aihara K, Fukuda D, Takashima A . Serum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery disease. Nutr J. 2014; 13(1):112. PMC: 4391466. DOI: 10.1186/1475-2891-13-112. View